Repligen Corporation (RGEN) earnings · rev $738.3M
These earnings events as JSON? API free 100/dayRepligen Corporation (RGEN) is a medical instruments & supplies company listed on NASDAQ.
This RGEN earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported RGEN revenue for 2025-12-31 was $738.3M. Net income was $48.9M. Revenue was up 16.4% from 2024-12-31 to 2025-12-31. RGEN currently screens at market cap $7.43B.
When the next RGEN 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 16.4% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full RGEN research stays on the stock page; the tape stays on the quote page.
RGEN earnings FAQ
What are RGEN's latest revenue and net income?
Latest cached Repligen Corporation (RGEN) revenue for Dec 31, 2025 was $738.3M. Net income was $48.9M. Statements: https://lician.com/financials/rgen
What is RGEN's latest diluted EPS?
Latest cached Repligen Corporation (RGEN) diluted EPS for Dec 31, 2025 was $0.86.
What period does the latest RGEN earnings print cover?
The latest cached Repligen Corporation (RGEN) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did RGEN revenue change from the prior cached period?
Cached Repligen Corporation (RGEN) revenue was up 16.4% from $634.4M (Dec 31, 2024) to $738.3M (Dec 31, 2025). Statements: https://lician.com/financials/rgen
Where are RGEN earnings listed?
Cached earnings facts for Repligen Corporation (RGEN) are listed at https://lician.com/earnings/rgen. Statements: https://lician.com/financials/rgen
Not investment advice.